
This Slide: #56 of 100 |
Slide #56. ICON — Aptiv Solutions
Acquirer:
ICON (NASDAQ:ICLR)
Acquiree:
Aptiv Solutions
Details:
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for a cash consideration of $143.5 million. Aptiv Solutions is owned by The Halifax Group, SV Life Sciences, Comvest Partners and Management.
ICON provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. Co. provides a range of clinical, consulting and commercial services ranging from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. Co. focuses on development, management and analysis of programs that support clinical development process.
Open the ICLR Page at The Online Investor »
|
Open the ICLR Page at The Online Investor (in a new window) »

![]() ![]() Get SEC Filing Alerts Get Dividend Alerts ![]() ![]() |
![]() Buy (3.33 out of 4) 38th percentile
(ranked lower than approx. 62% of all stocks covered)
Analysts' Target Price: ICLR Stock Forecast Based on Zacks ABR data; powered by Xignite ![]() |
